The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States
-
- Amy C Sherman
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
-
- Ahmed Babiker
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
-
- Andrew J Sieben
- Emory University School of Medicine, Atlanta, Georgia, USA
-
- Alexander Pyden
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
-
- James Steinberg
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
-
- Colleen S Kraft
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
-
- Katia Koelle
- Department of Biology, Emory University, Atlanta, Georgia, USA
-
- Sanjat Kanjilal
- Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts, USA
抄録
<jats:title>Abstract</jats:title> <jats:p>To assess the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on seasonal respiratory viruses, absolute case counts and viral reproductive rates from 2019–2020 were compared against previous seasons. Our findings suggest that the public health measures implemented to reduce SARS-CoV-2 transmission significantly reduced the transmission of other respiratory viruses.</jats:p>
収録刊行物
-
- Clinical Infectious Diseases
-
Clinical Infectious Diseases 72 (5), e154-e157, 2020-11-08
Oxford University Press (OUP)